<DOC>
	<DOCNO>NCT00651638</DOCNO>
	<brief_summary>To assess PK safety profile ARQ 197 extensive poor metabolizers , define CYP 2C19 genotype</brief_summary>
	<brief_title>A Study ARQ 197 Healthy Volunteers Assess Pharmacokinetic ( PK ) Profile Extensive Poor Metabolizers Defined Cytochrome P450 2C19 ( CYP 2C19 ) Genotype</brief_title>
	<detailed_description>This pharmacokinetic study design compare metabolism ARQ 197 normal healthy volunteer extensive metabolizers ( EM ) poor metabolizers ( PM ) define CYP 2C19 genotype . This open-label , single-dose , parallel group design healthy volunteer subject receive single dose ARQ 197</detailed_description>
	<criteria>Subject must provide write informed consent prior study related procedure Subjects must age 18 65 year old Male participant must surgically sterilize Female participant must surgically sterilize post menopausal must negative serum pregnancy test . Post Menopausal define least one year without menses . Subject must , opinion Investigator , willing able complete study procedure Subject must provide write informed consent prior study related procedure Subjects must age 18 65 year old Male participant must surgically sterilize Female participant must surgically sterilize post menopausal must negative serum pregnancy test . Post Menopausal define least one year without menses . Subject must , opinion Investigator , willing able complete study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>PK safety profile ARQ 197</keyword>
</DOC>